SCHEMBL31480229

SCHEMBL31480229

CNc1cc(C(=O)OC)ccc1C1CCCCN1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HPGD P15428 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
NPC1 O15118 1/20 0.37
EPHX2 P34913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31480424 0.88 YAP1 (0.44) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL16409252 0.85 SMN1; SMN2 (0.45) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL17782315 0.84 MEN1 (0.42) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL17782313 0.84 MEN1 (0.42) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL31480074 0.84 SLC6A3 (0.43) ALDH1A1MEN1KMT2ASMN1; SMN2ATM
SCHEMBL4150927 0.81 MEN1 (0.47) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL31480101 0.80 HPGD (0.56) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL31480357 0.80 KDM4E (0.51) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL31480262 0.80 ALDH1A1 (0.38) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL14194494 0.80 MEN1 (0.46) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054361-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed